CLOV logo

Clover Health Investments, Corp. Stock Price

NasdaqGS:CLOV Community·US$2.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 106 Fair Values set on narratives written by author

CLOV Share Price Performance

US$4.17
1.29 (44.79%)
US$5.50
Fair Value
US$4.17
1.29 (44.79%)
24.2% undervalued intrinsic discount
US$5.50
Fair Value
Price US$4.17
AnalystHighTarget US$5.50
AnalystConsensusTarget US$4.15
AnalystLowTarget US$3.50

CLOV Community Narratives

·
Fair Value US$5.5 24.2% undervalued intrinsic discount

Digital Healthcare And Medicare Advantage Will Unlock Long-term Opportunities

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$4.15 0.5% overvalued intrinsic discount

Margin Pressures and Healthcare Reforms Will Influence Future Medicare Advantage Dynamics

1users have liked this narrative
0users have commented on this narrative
44users have followed this narrative
·
Fair Value US$3.5 19.1% overvalued intrinsic discount

Rising Costs And Regulation Will Erode Medicare Advantage Profitability

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

CLOV logo

CLOV: Cleaner Earnings Season Setup Will Test Rebounding Managed Care Tailwinds

Fair Value: US$5.5 24.2% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLOV logo

CLOV: Elevated P/E Expectations Will Pressure Returns Despite Recent Operational Tailwinds

Fair Value: US$4.15 0.5% overvalued intrinsic discount
44 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLOV logo

CLOV: Elevated P E Expectations Will Likely Pressure Future Share Returns

Fair Value: US$3.5 19.1% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet and undervalued.

1 Risk
3 Rewards

Clover Health Investments, Corp. Key Details

US$2.2b

Revenue

US$1.8b

Cost of Revenue

US$405.8m

Gross Profit

US$462.7m

Other Expenses

-US$56.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 05, 2026
-0.11
18.36%
-2.58%
0%
View Full Analysis

About CLOV

Founded
2014
Employees
724
CEO
Andrew Toy
WebsiteView website
www.cloverhealth.com

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Recent CLOV News & Updates

Narrative Update Jul 27

CLOV: Cleaner Earnings Season Setup Will Test Rebounding Managed Care Tailwinds

The analyst price target for Clover Health Investments has increased from $4.75 to $5.50, as analysts factor in updated models ahead of earnings season and look for a cleaner upcoming quarter to justify potential additional stock gains. Analyst Commentary Recent research on Clover Health Investments shows a cluster of upward price target revisions, indicating that bullish analysts see room for further upside if the company executes well around upcoming earnings.

Recent updates

No updates